Purple Innovation, Inc. reports developments around its branded sleep-products business, built on GelFlex Grid technology and sold through e-commerce, wholesale partners, company showrooms, and third-party online retailers. News commonly covers quarterly revenue and margin performance, adjusted EBITDA, showroom comparable sales, e-commerce trends, and wholesale distribution with retail partners.
Company updates also address product and brand momentum across mattresses, pillows, bedding, and cushions, including premium mattress lines such as Purple Royale and Rejuvenate 2.0. Other recurring subjects include operating-efficiency initiatives, debt amendments, earnings-call schedules, and leadership or finance-function changes.
Purple Innovation (NASDAQ: PRPL) will report fourth quarter and full year 2025 financial results on March 25, 2026 at approximately 8:00 a.m. ET. The company will host a conference call at 8:30 a.m. ET with dial-in and live webcast options.
A telephone replay is available through April 1, 2026, and a webcast replay will remain on the investor relations site for one year. Investors should register on the webcast site at least 15 minutes before the call.
Purple (NASDAQ: PRPL) announced independent SleepScore Labs studies showing Purple Essentials and Purple Restore mattresses with GelFlex Grid reduced self-reported nighttime pain disruptions and improved measured sleep across two 10-week, in-home trials covering >3,300 nights.
Key results: pain reductions of 68% (Essentials) and 63% (Restore); Essentials users fell asleep 8% faster and woke 6% less often; Restore users gained +3.5 hours deep sleep/month and +7 hours total sleep/month, with sleep quality +3% and efficiency +2%. Self-reported morning restoration and satisfaction rose substantially for both collections.
Purple (NASDAQ: PRPL) announced results from two independent 10-week, in-home SleepScore Labs studies of its Essentials and Restore mattresses with GelFlex Grid technology.
Across more than 3,300 nights of objective and self-reported data, participants reported nighttime pain reductions of 68% (Essentials) and 63% (Restore), plus large gains in morning restoration, sleep quality, and satisfaction (Essentials: +90%–+127%; Restore: +170%–+214%). Objectively measured changes included faster sleep onset (Essentials) and more deep sleep and longer monthly sleep time (Restore).
Interested partners can discuss the findings at Purple's Las Vegas Winter Market showroom on January 26, 2026.
Purple Innovation (NASDAQ: PRPL) reported third quarter 2025 results on Nov 4, 2025, highlighting a continued profitability turnaround. Q3 net revenue was $118.8M versus $118.6M year‑ago. Gross profit rose to $50.9M (42.8% of revenue) and adjusted gross margin expanded by 230 basis points vs. the prior year. Operating expense fell 23.2% to $63.0M. Net loss narrowed to $11.7M from $39.2M, and adjusted EBITDA improved to $0.2M from $(6.4)M. Cash was $32.4M and net inventories were $65.8M (up 9.8% YoY). The company maintained full‑year 2025 guidance: $465–$485M revenue and adjusted EBITDA breakeven to $10M.
Management cited Rejuvenate 2.0, Mattress Firm rollout, showroom strength and manufacturing efficiencies as drivers of momentum while e‑commerce remained softer.
Purple Innovation (NASDAQ: PRPL) will report third quarter 2025 financial results on Tuesday, November 4, 2025 at approximately 4:05 p.m. ET.
The company will host a conference call at 4:30 p.m. ET the same day; domestic dial-in is 800-715-9871, international dial-in is 646-307-1963, Conference ID 7609054. A live webcast will be available at investors.purple.com (register at least 15 minutes early).
A telephone replay is available until November 11, 2025 at 800-770-2030 with Conference ID 7609054, and a webcast replay will remain on the investor relations site for one year.
Purple Innovation (NASDAQ: PRPL) reported Q2 2025 results with mixed performance. Net revenue declined 12.6% to $105.1 million compared to Q2 2024, while net loss was $(17.3) million. Despite revenue decline, Adjusted EBITDA improved to $(2.4) million from $(4.1) million last year, showing a 120 basis point margin improvement.
The company's Rejuvenate 2.0 collection launch showed strong demand, achieving more than double the success of Rejuvenate 1.0. Purple maintains its 2025 guidance of $465-485 million in revenue and adjusted EBITDA of $0-10 million. The company's cash position strengthened to $34.2 million, while inventory levels decreased 12.6% year-over-year.
Purple Innovation (NASDAQ: PRPL) has scheduled its second quarter 2025 financial results announcement for July 29, 2025 at approximately 4:05 p.m. ET. The comfort innovation company will host a conference call at 4:30 p.m. ET on the same day to discuss the results.
Investors and analysts can participate by dialing 800-715-9871 (domestic) or 646-307-1963 (international) with Conference ID 7609054. A live webcast will be available at investors.purple.com. A telephone replay will be accessible until August 5, 2025, and a webcast replay will remain available for one year on the company's investor relations website.
Purple Innovation (NASDAQ: PRPL), known for creating the "World's First No Pressure™ Mattress," has scheduled its first quarter 2025 financial results announcement for May 6, 2025 at approximately 4:05 p.m. ET. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results.
Investors and analysts can participate by dialing 800-715-9871 (domestic) or 646-307-1963 (international) with Conference ID 7609054. A live webcast will be available at investors.purple.com. A telephone replay will be accessible until May 13, 2025, and a webcast replay will remain available for 30 days on the company's investor relations website.